BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol 2016; 22(44): 9674-9693 [PMID: 27956792 DOI: 10.3748/wjg.v22.i44.9674]
URL: https://www.wjgnet.com/1948-5182/full/v22/i44/9674.htm
Number Citing Articles
1
Masahiro Ohira, Shou Tanaka, Yasuhiro Watanabe, Shoko Nakamura, Rena Oka, Takashi Yamaguchi, Noriko Ban, Atsuhito Saiki, Noriko Ishihara, Takeyoshi Murano, Takayo Murase, Takashi Nakamura, Ichiro Tatsuno. Association of Plasma Xanthine Oxidoreductase with Arterial Stiffness in Type 2 Diabetes with Liver DysfunctionThe American Journal of the Medical Sciences 2021;  doi: 10.1016/j.amjms.2021.09.011
2
Adrian Curran, Anna Rull, Jordi Navarro, Judit Vidal-González, Mario Martin-Castillo, Joaquin Burgos, Vicenç Falcó, Esteban Ribera, Ariadna Torrella, Bibiana Planas, Joaquim Peraire, Manuel Crespo. Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label TrialJournal of Clinical Medicine 2020; 9(5): 1246 doi: 10.3390/jcm9051246
3
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patientsDigestive and Liver Disease 2019; 51(1): 142 doi: 10.1016/j.dld.2018.07.003
4
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher. “ Not all forms of NAFLD were created equal ”. Do metabolic syndrome-related NAFLD and PNPLA3 -related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?Atherosclerosis 2017; 257: 253 doi: 10.1016/j.atherosclerosis.2017.01.008
5
Hyun-Woo Joo, Yi-Sun Song, In-Hwa Park, Guang-Yin Shen, Jin-Hee Seong, Na-Kyoung Shin, A-Hyeon Lee, Hyuck Kim, Kyung-Soo Kim. Granulocyte Colony Stimulating Factor Ameliorates Hepatic Steatosis Associated with Improvement of Autophagy in Diabetic RatsCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/2156829
6
Farouk K. El-Baz, Dalia O. Saleh, Gehad A. Abdel Jaleel, Rehab A. Hussein. Attenuation of Age-Related Hepatic Steatosis by Dunaliella salina Microalgae in Senescence Rats through the Regulation of Redox Status, Inflammatory Indices, and Apoptotic BiomarkersAdvances in Pharmacological and Pharmaceutical Sciences 2020; 2020: 1 doi: 10.1155/2020/3797218
7
A A Svistunov, M A Osadchuk, N V Kireeva, M M Osadchuk. Optimizing therapy of liver diseases not associated with viral infectionTerapevticheskii arkhiv 2018; 90(2): 94 doi: 10.26442/terarkh2018902105-111
8
Duanghathai Pasanta, Montree Tungjai, Sirirat Chancharunee, Warayuth Sajomsang, Suchart Kothan. Body mass index and its effects on liver fat content in overweight and obese young adults by proton magnetic resonance spectroscopy techniqueWorld Journal of Hepatology 2018; 10(12): 924-933 doi: 10.4254/wjh.v10.i12.924
9
Gabriella Bueno Marinho, Jefferson Rocha Tenório, Luciana Munhoz, Natália Silva Andrade, Emiko Saito Arita, Karem L. Ortega. Detection of calcified atheromas on panoramic radiographs of cirrhotic patientsSpecial Care in Dentistry 2021; 41(2): 164 doi: 10.1111/scd.12551
10
Soon Sun Kim, Hyo Jung Cho, Hyun Ji Kim, Dae Ryong Kang, Jacob R. Berry, Jin Hong Kim, Min Jae Yang, Sun Gyo Lim, SooJin Kim, Jae Youn Cheong, Sung Won Cho. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjectsDigestive and Liver Disease 2018; 50(4): 370 doi: 10.1016/j.dld.2017.12.018
11
Makan Cheraghpour, Hossein Imani, Shahrzad Ommi, Seyed Moayed Alavian, Elahe Karimi‐Shahrbabak, Mehdi Hedayati, Zahra Yari, Azita Hekmatdoost. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trialPhytotherapy Research 2019; 33(8): 2118 doi: 10.1002/ptr.6406
12
Yebei Liang, Mao Ye, Xuhong Hou, Peizhu Chen, Li Wei, Fusong Jiang, Liang Feng, Lichang Zhong, Huaiyu Liu, Yuqian Bao, Weiping Jia. Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly ChineseDiabetes Research and Clinical Practice 2020; 169: 108385 doi: 10.1016/j.diabres.2020.108385
13
Ravirajsinh N. Jadeja, Malita A. Jones, Ollya Fromal, Folami L. Powell, Sandeep Khurana, Nagendra Singh, Pamela M. Martin. Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosisAging 2019; 11(2): 386 doi: 10.18632/aging.101743
14
Katti R. Crakes, Clarissa Santos Rocha, Irina Grishina, Lauren A. Hirao, Eleonora Napoli, Christopher A. Gaulke, Anne Fenton, Sandipan Datta, Juan Arredondo, Maria L. Marco, Sumathi Sankaran-Walters, Gino Cortopassi, Cecilia Giulivi, Satya Dandekar. PPARα-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host–microbe intersection during SIV infectionProceedings of the National Academy of Sciences 2019; 116(49): 24819 doi: 10.1073/pnas.1908977116
15
Zobair M. Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael R. Charlton, Naga P. Chalasani, Quentin M. Anstee, Kris V. Kowdley, Jacob George, Zachary D. Goodman, Keith Lindor. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology 2018; 68(1): 361 doi: 10.1002/hep.29724
16
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
17
Juergen Eckel. The Cellular Secretome and Organ Crosstalk2018; : 117 doi: 10.1016/B978-0-12-809518-8.00005-2
18
Ivan Linares, Matyas Hamar, Nazia Selzner, Markus Selzner. Steatosis in Liver Transplantation: Current Limitations and Future StrategiesTransplantation 2019; 103(1): 78 doi: 10.1097/TP.0000000000002466
19
Alaa Badawi, Giancarlo Di Giuseppe, Alind Gupta, Abbey Poirier, Paul Arora. Bayesian network modelling study to identify factors influencing the risk of cardiovascular disease in Canadian adults with hepatitis C virus infectionBMJ Open 2020; 10(5): e035867 doi: 10.1136/bmjopen-2019-035867
20
Netanya S Utay, Douglas W Kitch, Eunice Yeh, Carl J Fichtenbaum, Michael M Lederman, Jacob D Estes, Claire Deleage, Clara Magyar, Scott D Nelson, Karen L Klingman, Barbara Bastow, Amneris E Luque, Grace A McComsey, Daniel C Douek, Judith S Currier, Jordan E Lake, Francesca Aweeka, Jenifer Baer, Alex Benns, Joan Dragavon, Christopher Hensel, Priscilla Hsue, Andy Kaytes, Heather Ribaudo, David Rusin, Katherine Shin, Antoine Simmons, Xinyan Zhan. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy AloneThe Journal of Infectious Diseases 2018; 217(11): 1770 doi: 10.1093/infdis/jiy064
21
Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael R. Charlton, Zachary D. Goodman, Naga P. Chalasani, Kris V. Kowdley, Jacob George, Keith Lindor. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisHepatology 2018; 68(1): 349 doi: 10.1002/hep.29721
22
Zobair M. Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysisJournal of Hepatology 2019; 71(4): 793 doi: 10.1016/j.jhep.2019.06.021
23
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri, Nicola Coppola. Advances in Microbiology, Infectious Diseases and Public HealthAdvances in Experimental Medicine and Biology 2020; 1323: 115 doi: 10.1007/5584_2020_604
24
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral TreatmentsBiomedicines 2021; 9(10): 1491 doi: 10.3390/biomedicines9101491
25
Narjeet S. Khurmi, Yu-Hui Chang, D. Eric Steidley, Andrew L. Singer, Winston R. Hewitt, Kunam S. Reddy, Adyr A. Moss, Amit K. Mathur. Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United StatesLiver Transplantation 2018; 24(10): 1398 doi: 10.1002/lt.25055
26
Zheng Li, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren, Luyong Zhang. ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosisPharmacological Research 2020; 159: 105035 doi: 10.1016/j.phrs.2020.105035
27
Cassidy Williams, Festus M. Kamau, Frans Everson, Boipelo Kgokane, Patrick De Boever, Nandu Goswami, Ingrid Webster, Hans Strijdom. HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South AfricaJournal of Clinical Medicine 2021; 10(18): 4112 doi: 10.3390/jcm10184112
28
Lan Bai, Hongliang Li. Innate immune regulatory networks in hepatic lipid metabolismJournal of Molecular Medicine 2019; 97(5): 593 doi: 10.1007/s00109-019-01765-1
29
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
30
Sui-Weng Wong, Wah-Kheong Chan. Epidemiology of non-alcoholic fatty liver disease in AsiaIndian Journal of Gastroenterology 2020; 39(1): 1 doi: 10.1007/s12664-020-01018-x
31
Fatemeh Kazeminasab, Sayed Mohammad Marandi, Maryam Baharlooie, Mohammad Hossein Nasr-Esfahani, Kamran Ghaedi. Modulation and bioinformatics screening of hepatic mRNA-lncRNAs (HML) network associated with insulin resistance in prediabetic and exercised miceNutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00600-0
32
S Singh, KK Kharbanda. Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A ReviewArchives of Hepatitis Research 2017; 3(1): 029 doi: 10.17352/ahr.000014
33
Jordan E. Lake. The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV InfectionCurrent HIV/AIDS Reports 2017; 14(6): 211 doi: 10.1007/s11904-017-0368-6
34
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetesMetabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
35
Yutaka Takahashi. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the LiverInternational Journal of Molecular Sciences 2017; 18(7): 1447 doi: 10.3390/ijms18071447
36
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and ManagementEndocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
37
Keishi Ichikawa, Toru Miyoshi, Kazuhiro Osawa, Takashi Miki, Hironobu Toda, Kentaro Ejiri, Masatoki Yoshida, Yusuke Nanba, Masashi Yoshida, Kazufumi Nakamura, Hiroshi Morita, Hiroshi Ito. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort studyCardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-020-01192-4
38
Veera Houttu, Susanne Csader, Max Nieuwdorp, Adriaan G. Holleboom, Ursula Schwab. Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.716783
39
Takumi Kawaguchi, Hironori Koga, Takuji Torimura. Recent Advances in the Pathogenesis of Hepatitis C Virus-Related Non-Alcoholic Fatty Liver Disease and Its Impact on Patients Cured of Hepatitis CCurrent Hepatology Reports 2017; 16(4): 317 doi: 10.1007/s11901-017-0370-x
40
Yoshitaka Hashimoto, Masahide Hamaguchi, Muhei Tanaka, Akihiro Obora, Takao Kojima, Michiaki Fukui. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studiesObesity Research & Clinical Practice 2018; 12(1): 4 doi: 10.1016/j.orcp.2017.12.003
41
Giovanni Guaraldi, Amedeo Lonardo, Liliana Maia, Frank J. Palella. Metabolic concerns in aging HIV-infected personsAIDS 2017; 31(Supplement 2): S147 doi: 10.1097/QAD.0000000000001483
42
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A reviewWorld Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
43
Guglielmo M Trovato. Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformaticsWorld Journal of Gastrointestinal Pathophysiology 2020; 11(3): 57-63 doi: 10.4291/wjgp.v11.i3.57
44
Oren Tirosh. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease ProgressionOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/2548154
45
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares-da-Silva. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?Hepatology International 2021; 15(2): 380 doi: 10.1007/s12072-021-10157-y
46
Ludovico Abenavoli, Marta Greco, Natasa Milic, Francesca Accattato, Daniela Foti, Elio Gulletta, Francesco Luzza. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized StudyNutrients 2017; 9(8): 870 doi: 10.3390/nu9080870
47
Bing bing Chen, Ying Han, Xinting Pan, Jianhui Yan, Wenjuan Liu, Yangfan Li, Xu Lin, Shanghua Xu, Xian-E Peng. Association between nut intake and non-alcoholic fatty liver disease risk: a retrospective case-control study in a sample of Chinese Han adultsBMJ Open 2019; 9(9): e028961 doi: 10.1136/bmjopen-2019-028961
48
P. Vineeth Daniel, Surbhi Dogra, Priya Rawat, Abhinav Choubey, Aiysha Siddiq Khan, Sangam Rajak, Mohan Kamthan, Prosenjit Mondal. NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate dietJournal of Biological Chemistry 2021; 296: 100714 doi: 10.1016/j.jbc.2021.100714
49
Pratima Dibba, Rosann Cholankeril, Andrew Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in PregnancyDiseases 2018; 6(2): 31 doi: 10.3390/diseases6020031
50
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
51
Maria J. Peláez-Jaramillo, Allison A. Cárdenas-Mojica, Paula V. Gaete, Carlos O. Mendivil. Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to TreatmentDiabetes Therapy 2018; 9(2): 521 doi: 10.1007/s13300-018-0374-8
52
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
53
Amedeo Lonardo, Ayako Suzuki. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational ResearchJournal of Clinical Medicine 2020; 9(5): 1278 doi: 10.3390/jcm9051278
54
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataAlimentary Pharmacology & Therapeutics 2020; 51(11): 1149 doi: 10.1111/apt.15679
55
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim, Won-Hwan Park. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4589810
56
Filippo Valbusa, Stefano Bonapace, Davide Agnoletti, Luca Scala, Cristina Grillo, Pietro Arduini, Emanuela Turcato, Alessandro Mantovani, Giacomo Zoppini, Guido Arcaro, Christopher Byrne, Giovanni Targher, Anna Alisi. Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failurePLOS ONE 2017; 12(3): e0173398 doi: 10.1371/journal.pone.0173398
57
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral TherapyHepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
58
Fatemeh Farshadpour, Reza Taherkhani, Mohammad Reza Ravanbod, Seyed Sajjad Eghbali. Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes MellitusMedical Principles and Practice 2018; 27(4): 308 doi: 10.1159/000488985
59
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of viewExploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
60
Bahare Fazeli, Daniela Ligi, Shayan Keramat, Rosanna Maniscalco, Hiva Sharebiani, Ferdinando Mannello. Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical ConsequencesDiagnostics 2021; 11(10): 1736 doi: 10.3390/diagnostics11101736
61
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adultsExpert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
62
Trevor J. Orchard, Bertrand Cariou, Margery A. Connelly, James D. Otvos, Shuyu Zhang, Caryl J. Antalis, Tibor Ivanyi, Byron J. Hoogwerf. The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetesCardiovascular Diabetology 2017; 16(1) doi: 10.1186/s12933-017-0555-1
63
M. A. Arzhakova, T. A. Shekhovtsova, D. V. Duplyakov. Coronary Heart Disease in HIV-Infected PatientsRational Pharmacotherapy in Cardiology 2020; 15(6): 900 doi: 10.20996/1819-6446-2019-15-6-900-905
64
Shao Mei Sun, Yan Yan Wang, Qing Zhang, Li Liu, Ge Meng, Zhan Xin Yao, Hong Mei Wu, Yang Xia, Xue Bao, Ye Qing Gu, Hong Lei Wang, Hong Bin Shi, Hai Yan Xu, Xing Wang, Ming Zhou, Huan Li Jiao, Qi Yu Jia, Bang Mao Wang, Kai Jun Niu. Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver diseaseJournal of Digestive Diseases 2018; 19(8): 498 doi: 10.1111/1751-2980.12646
65
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Pharmacological Research 2018; 137: 219 doi: 10.1016/j.phrs.2018.09.025
66
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Mauro Maurantonio. A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?Acta Diabetologica 2019; 56(4): 385 doi: 10.1007/s00592-018-1266-0
67
Lesley Hoyles, José-Manuel Fernández-Real, Massimo Federici, Matteo Serino, James Abbott, Julie Charpentier, Christophe Heymes, Jèssica Latorre Luque, Elodie Anthony, Richard H. Barton, Julien Chilloux, Antonis Myridakis, Laura Martinez-Gili, José Maria Moreno-Navarrete, Fadila Benhamed, Vincent Azalbert, Vincent Blasco-Baque, Josep Puig, Gemma Xifra, Wifredo Ricart, Christopher Tomlinson, Mark Woodbridge, Marina Cardellini, Francesca Davato, Iris Cardolini, Ottavia Porzio, Paolo Gentileschi, Frédéric Lopez, Fabienne Foufelle, Sarah A. Butcher, Elaine Holmes, Jeremy K. Nicholson, Catherine Postic, Rémy Burcelin, Marc-Emmanuel Dumas. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese womenNature Medicine 2018; 24(7): 1070 doi: 10.1038/s41591-018-0061-3
68
Niki Katsiki, Vasilios G. Athyros, Dimitri P. Mikhailidis. Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugsJournal of Diabetes and its Complications 2017; 31(3): 521 doi: 10.1016/j.jdiacomp.2016.12.006
69
Vita Dikariyanto, Leanne Smith, Lucy Francis, May Robertson, Eslem Kusaslan, Molly O'Callaghan-Latham, Camille Palanche, Maria D'Annibale, Dimitra Christodoulou, Nicolas Basty, Brandon Whitcher, Haris Shuaib, Geoffrey Charles-Edwards, Philip J Chowienczyk, Peter R Ellis, Sarah E E Berry, Wendy L Hall. Snacking on whole almonds for 6 weeks improves endothelial function and lowers LDL cholesterol but does not affect liver fat and other cardiometabolic risk factors in healthy adults: the ATTIS study, a randomized controlled trialThe American Journal of Clinical Nutrition 2020; 111(6): 1178 doi: 10.1093/ajcn/nqaa100
70
Amedeo Lonardo, Alessandro Mantovani. Clearing hepatitis C virus with direct antiviral agents reduces cardiovascular events in patients with prediabetes. Commentary to Sasso and colleaguesNutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2354 doi: 10.1016/j.numecd.2021.05.019